You are here: Home » Companies » News
Business Standard

Sun Pharma, Britain's AstraZeneca join to distribute cancer drugs in China

The financial terms of the agreement, which has an initial tenure of 10 years, were not disclosed

Reuters  |  Bengaluru 

Drugs, Pharma, medicine

Indian drugmaker Ltd said on Wednesday it would introduce some of its cancer treatment drugs in China through Britain's

This comes after said it was launching a new fund with China International Capital Corp to invest $1 billion in China's healthcare sector, as it expands its research work in the country.

will be responsible for development, regulatory filings and manufacturing of the drugs covered in the deal, while will exclusively promote and distribute the products in China, according to a filing to Indian stock

The financial terms of the agreement, which has an initial tenure of 10 years, were not disclosed.

First Published: Wed, November 06 2019. 08:57 IST
RECOMMENDED FOR YOU